Formulations of bendamustine | Patent Number 09597397

US 09597397 B2
Application Number14857064
Publication NumberUS 20160000759 A1
Pendency1 year, 6 months, 6 days
Filled DateSep 17, 2015
Priority DateMar 20, 2012
Publication DateJan 7, 2016
Expiration DateMar 19, 2032
Inventor/ApplicantsSrikanth Sundaram
ExaminesIVANOVA, SVETLANA M
Art Unit1627
Technology Center1600
Assignments
Jpmorgan Chase Bank
Current
Eagle Pharmaceuticals Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.